title: Results of four different protocols for prophylaxis against graft-versus-host disease.
authors.affiliation: Department of Clinical Immunology, Karolinska Institute, Stockholm, Sweden.
authors.forename: J
authors.initials: J
authors.lastname: Tollemar
authors.forename: O
authors.initials: O
authors.lastname: Ringdén
authors.forename: L
authors.initials: L
authors.lastname: Bäckman
authors.forename: G
authors.initials: G
authors.lastname: Janossy
authors.forename: B
authors.initials: B
authors.lastname: Lönnqvist
authors.forename: L
authors.initials: L
authors.lastname: Markling
authors.forename: P
authors.initials: P
authors.lastname: Philstedt
authors.forename: B
authors.initials: B
authors.lastname: Sundberg
mesh_terms: D000208:Acute Disease; D000328:Adult; D016026:Bone Marrow Transplantation; D002986:Clinical Trials as Topic; D003524:Cyclosporins / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006086:Graft vs Host Disease / Q000209:etiology / Q000401:mortality / Q000517:prevention & control*; D006801:Humans; D007938:Leukemia / Q000401:mortality / Q000601:surgery; D008212:Lymphocyte Depletion; D008223:Lymphoma / Q000401:mortality / Q000601:surgery; D008727:Methotrexate / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000209:etiology / Q000401:mortality / Q000517:prevention & control; D011897:Random Allocation; D012008:Recurrence; D013601:T-Lymphocytes
chemical_list: D003524:Cyclosporins; D008727:Methotrexate